Kriya Appoints Katherine Eade as Chief Legal Officer
– Experienced biopharma executive to guide Kriya’s overarching legal strategy across corporate affairs, gene therapy R&D, and technology & manufacturing...
Neurology
OnlineMedEd Expands No-Cost Clinical Sciences Question Bank and Introduces PA Qbank, Freeing More Medical Students from Financial Burden
Updates help secure sustainable careers and enhance well-being; 5,400+ students have registered since April AUSTIN, Texas, June 18, 2024 /PRNewswire/...
MCRA Supports 3D Systems with 510(k) FDA Clearance for VSP PEEK Cranial Implant Device
WASHINGTON, June 18, 2024 /PRNewswire/ -- MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization...
Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024
MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a...
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
With today’s announcement of the transaction completion, Grifols and Haier Group will work together through Shanghai RAAS (SRAAS) to drive...
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
LAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching...
Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis
MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid...
Springbok Analytics Announces Phase 1 Clinical Trial Evaluating Clenbuterol as FSHD Treatment
This dose escalation study for safety and tolerability of clenbuterol incorporates Springbok's precision muscle MRI analysis and molecular outcome measures...
Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)
Top-line results from Phase 2 MoMeNtum trial in Multifocal Motor Neuropathy anticipated in 2H 2026 Building a neuromuscular franchise with...
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Key scientific achievement advances the joint pipeline in the strategic neuroscience partnership with Bristol Myers Squibb and earns a payment...
Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to Drive Adoption of Digital Endpoints in Clinical Trials
Cumulus to participate in The Digital Health Measurement Collaborative Community (DATAcc) by DiMe project – Building the Business Case for...
AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer NEW ORLEANS, June 11, 2024 /PRNewswire/ -- AxoSim, a life...
Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, And Company Appoints CEO and President
SAN MATEO, Calif., June 10, 2024 /PRNewswire/ -- Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare...
Presentation at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting Highlights Ashvattha Product Candidates for Neuroinflammation Imaging and Treatment
Preclinical data highlights the therapeutic potential of Ashvattha’s novel CSF1R tyrosine kinase inhibitor (CSF1R dendranib) for multiple sclerosis (MS) based...
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
At #SNMMI24, GE HealthCare expands its technology with the addition of a MINItrace Magni,i designed to be a small footprint...
Klick Health Adds 18 Senior Leaders as 27-Year Double-Digit Growth Spurt Continues
Independent health agency continues to attract industry’s brightest minds; fortifies teams companywide as part of commitment to delivering industry-leading innovation,...
RapidAI Wins 2024 MedTech Breakthrough Award For “Best Care Coordination Platform”
Prestigious International Annual Awards Program Recognizes the Breakthrough Innovation of the RapidAI Clinical PlatformLOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE)...
QuantalX Partners with the University of Illinois Chicago, Towards Successful US Commercialization
NEW YORK, June 5, 2024 /PRNewswire/ -- QuantalX Neuroscience Ltd, a pioneering medical technology company, is delighted to announce its...
Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform
Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit...
GE HealthCare Pharmaco-Economic Study Demonstrates Adding Breast Oncology PET Tracer to Standard Workup of Patients with Metastatic or Recurrent Breast Cancer May Yield Beneficial Clinical and Economic Outcomes, Potentially Saving $142M Over Five…
Adding a PET/CT scan with FES, a breast oncology PET tracer, may increase the accuracy of knowing the estrogen receptor...